LOS ANGELES, February 17, 2015 /PRNewswire/ --
Crossing Rivers Health is utilizing the CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solution for Rural Healthcare to improve clinical care and lower the cost of healthcare delivery within its clinics and hospitals.
(Logo: http://photos.prnewswire.com/prnh/20140721/697628 )
The CompuMed solution provides real-time access to its network of Board-Certified specialists for interpretations of diagnostic studies and critical care consulting, as well as world-class, telemedicine-enabled medical devices.
"CompuMed's Enterprise Telemedicine Solution for Rural Healthcare enables Crossing Rivers to deliver on our mission of meeting the health and wellness needs of our communities. We particularly like the quality and timeliness of the reports we receive from CompuMed's team of Board-Certified specialists. Furthermore, their specialists and 24/7 customer support team is dependable and available when we need them most," said Tim Clark, Crossing Rivers Health, Director of Medical Imaging.
"We are proud to collaborate with Crossing Rivers Health, one of the premier Critical Access Hospitals within the U.S. We take the responsibility of delivering top patient care seriously and are thrilled by the benefits Crossing Rivers is receiving from CompuMed in this area," said W. Scott Rombach, CompuMed's President and CEO.
Details of CompuMed's Enterprise Solution for Rural Healthcare can be viewed at compumedinc.com.
About CompuMed, Inc.
CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumedinc.com.
Forward-Looking Statements
Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.
CompuMed, Inc.
Investor Relations
investorrelations@compumed.net
(310) 258-5000 x117
Share this article